Qbrexza: a new drug to reduce excessive sweating
U.S. regulators have recently approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives.
The Food and Drug Administration approved Qbrexza (manufactured by Dermira Inc.) for excessive underarm sweating and will be available in October 2018.
The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.
An estimated 15.3 million Americans have some form of excessive sweating, but only 1 in 4 get treatment.
Current treatment options include Botox injections, surgery to remove sweat glands, procedures using lasers and other devices, and drugs approved for other conditions that block the body’s chemical messengers to reduce sweat production throughout the body.
